Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration

NCT04700423 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

536

Enrollment

OTHER

Sponsor class

Conditions

Trichuriasis
Ascariasis
Hookworm Infections
Helminthes; Infestation, Intestinal

Interventions

DRUG: moxidectin (8 mg) / albendazole (400 mg)
DRUG: ivermectin (200 µg/kg) / albendazole (400 mg)
DRUG: ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL]
DRUG: ivermectin (200 µg/kg)
DRUG: moxidectin (8 mg)

Sponsor

Jennifer Keiser

Collaborators

[object Object]